Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

Choose more journals

Article type Check one or more article types to show results from those article types only.
Subject Check one or more subjects to show results from those subjects only.
Date Choose a date option to show results from those dates only.

Custom date range

Clear all filters
Sort by:
Showing 1–28 of 28 results
Advanced filters: Author: Esther Landhuis Clear advanced filters

  • Nature Biotechnology’s annual survey highlights university startups that are, among other things, rethinking how to deliver gene-editing therapy and tackling various metabolic conditions, immune disorders and cancer with microbiome treatments or immunotherapy. Michael Eisenstein, Ken Garber, Esther Landhuis, Caroline Seydel and Laura DeFrancesco report.

    • Michael Eisenstein
    • Ken Garber
    • Laura DeFrancesco
    News
    Nature Biotechnology
    Volume: 39, P: 1036-1047

  • Our annual survey highlights startups taking on gene therapy, adoptive immune cell therapy, gene editing, and drugs targeting RNA modifications and the unfolded protein response. Ken Garber, Esther Landhuis, Melanie Senior, Cormac Sheridan and Laura DeFrancesco report.

    • Ken Garber
    • Esther Landhuis
    • Laura DeFrancesco
    Special Features
    Nature Biotechnology
    Volume: 37, P: 601-612

  • Protein- and sequencing-based technologies are helping researchers to profile immune cells ever more deeply.

    • Esther Landhuis
    Special Features
    Nature
    Volume: 557, P: 595-597

  • Plasma cells can be turned into protein factories for patients with protein deficiencies for whom one-and-done gene therapy is not an option.

    • Esther Landhuis
    News
    Nature Biotechnology

  • Nature Biotechnology’s annual survey highlights academic startups that are, among other things, designing circular RNA therapeutics, tackling cancer with arenaviruses, creating psychedelics without the trip, editing genes and cells in vivo, harnessing the power of autoantibodies and editing the epigenome.

    • Michael Eisenstein
    • Ken Garber
    • Laura DeFrancesco
    News
    Nature Biotechnology
    Volume: 40, P: 1551-1562

  • Although many postdocs and faculty members are leaving for industry or elsewhere, these researchers tell us why they love the academic life.

    • Esther Landhuis
    Comments & Opinion
    Nature
    Volume: 627, P: 453-454

  • COVID considerations unsurprisingly dominate the tech developments that could have a big impact in the coming year.

    • Esther Landhuis
    Special Features
    Nature
    Volume: 589, P: 630-632

  • The tools of chemical biology, genomics and data mining can yield insights into the metabolites of the microbiome.

    • Esther Landhuis
    Special Features
    Nature
    Volume: 573, P: 615-616

  • Artificial-intelligence methods are moving into cancer research.

    • Esther Landhuis
    Special Features
    Nature
    Volume: 580, P: 551-553

  • Artificial intelligence and improved microscopy make it feasible to map the nervous system at ever-higher resolution.

    • Esther Landhuis
    Special Features
    Nature
    Volume: 586, P: 631-633

  • Thought leaders predict the tech developments that could have a big impact in the coming year.

    • Esther Landhuis
    Special Features
    Nature
    Volume: 577, P: 585-587

  • No longer just ‘brain glue’, astrocytes are coming to the fore as a broadening toolset reveals the cells’ complexity and diversity.

    • Esther Landhuis
    Special Features
    Nature
    Volume: 563, P: 141-143

  • Neuroscientists are starting to share and integrate data — but shifting to a team approach isn't easy.

    • Esther Landhuis
    Special Features
    Nature
    Volume: 541, P: 559-561

  • Ultrasonic energy can be harnessed to alter brain activity and treat disease — but first, scientists need to learn how it works.

    • Esther Landhuis
    Special Features
    Nature
    Volume: 551, P: 257-259

  • As big pharma downsizes, contract research organizations are reaping the benefits.

    • Esther Landhuis
    Comments & Opinion
    Nature
    Volume: 556, P: 263-265

  • Biologists are diving into sugar-molecule research thanks to new tools and techniques.

    • Esther Landhuis
    Special Features
    Nature
    Volume: 547, P: 127-129

  • Warmer living conditions could make lab mice better models of human disease.

    • Esther Landhuis
    Special Features
    Lab Animal
    Volume: 47, P: 119-121